Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.

Achari AE, Jain SK. · 2017

Read Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. by Achari AE, Jain SK. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5486142.txt.

Description

Achari and Jain present a review in the International Journal of Molecular Sciences on adiponectin. Adiponectin is a protein released in large amounts by fat cells. Its level falls in obesity, and that drop plays a central role in related diseases. These include insulin resistance, type 2 diabetes, and heart disease. The authors review its control and actions.

The protein acts through two receptor types in liver, muscle, and blood vessels. Giving adiponectin improved insulin response in human and rodent studies, they report. It also calmed inflammation and slowed artery damage. The larger assembled forms seem to carry the strongest effects. Replacement therapy is weighed as a treatment idea.

Catalog record

CREATORAchari AE, Jain SK.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5486142

Browse the full library · About the Tower of Babel